Betafectin

Betafectin

A recombinant beta-glucan immunomodulator which was thought to reduce the risk of staphylococcal wound infection. It made it to phase-III clinical trials to prevent serious postoperative infection in GI surgical patients—e.g., for Crohn’s disease or ulcerative colitis.
References in periodicals archive ?
Alpha Beta Technology is a biotechnology company that manufactures Betafectin, an immunostimulant drug used to reduce infection rates in surgical patients.
5% of patients undergoing other high-risk surgeries will receives Betafectin at a cost of $500 per patient, generating revenues of $185 million.